Clinicopathologic Features and Outcomes of Metaplastic Breast Carcinoma: Comparison with Invasive Ductal Carcinoma of the Breast
Open Access
- 1 January 2010
- journal article
- Published by Yonsei University College of Medicine in Yonsei Medical Journal
- Vol. 51 (6) , 864-869
Abstract
Park HS, et al. Yonsei Med J. 2010 Nov;51(6):864-869. http://dx.doi.org/10.3349/ymj.2010.51.6.864Keywords
This publication has 35 references indexed in Scilit:
- What is triple-negative breast cancer?European Journal of Cancer, 2008
- Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysisBreast Cancer Research and Treatment, 2008
- Basal-like carcinoma of the breast: further evidence of the possibility that most metaplastic carcinomas may be actually basal-like carcinomasMedical Molecular Morphology, 2008
- Molecular analysis of metaplastic breast carcinoma: high EGFR copy number via aneusomyMolecular Cancer Therapeutics, 2008
- Basal carcinoma of the breast revisited: an old entity with new interpretationsJournal of Clinical Pathology, 2008
- Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literatureBreast Cancer Research and Treatment, 2006
- Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypesHuman Pathology, 2006
- Metaplastic breast carcinomas are negative for Her-2 but frequently express EGFR (Her-1): potential relevance to adjuvant treatment with EGFR tyrosine kinase inhibitors?Journal of Clinical Pathology, 2005
- Metaplastic breast carcinoma: clinical–pathologic characteristics and HER2/neu expressionBreast Cancer Research and Treatment, 2005
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001